BioCircuit Technologies logo — Precision made simple

BioCircuit Technologies

Precision made simple

Founded 2016 United States Atlanta, United States 30 employees Grant Total: $14.60M Biotechnology, Health Care +2

General Information

Company Name BioCircuit Technologies
Founded Year 2016
Location United States Atlanta, United States
Employees 30
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with BioCircuit Technologies. To contact BioCircuit Technologies, visit biocircuit.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About BioCircuit Technologies

BioCircuit Technologies is a medical device company that focuses on the development of tools for the repair of nerve and other tissues. Founded in 2016, the company operates in the Biotechnology, Health Care, and Manufacturing industries with its headquarters in the United States.

The company recently secured a significant $2.40M grant investment on 19 October 2023 from the National Institutes of Health. Their slogan, "Precision made simple," reflects their commitment to leveraging advanced technology to provide precise and accessible solutions in the medical field.

With their focus on addressing the need for innovative medical devices, BioCircuit Technologies stands out as a promising player in the biotechnology and healthcare sectors, attracting attention and support from notable institutions in the industry.

Taxonomy: electrophysiology, nerve repair, tissue repair, noninvasive, diagnosis tools, health monitoring, treatment selection, precision medicine

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $2.40M 1
National Institutes of Health
19 Oct 2023
Seed Round $9.00M 3
GRA Venture Fund, Michael W. Masters +1
27 Sep 2022
Grant $1.70M 1
National Institutes of Health
04 May 2021
Venture Round $1.50M -
28 May 2019
Debt Financing Undisclosed -
28 May 2019

BioCircuit Technologies Alternatives & Competitors

View All Alternatives
BioCircuit Technologies vs

Addressing a critical need to find cancer early and treat cancer at the cellular level.

Post-IPO Equity
22 employees
Biotechnology, Health Care
BioCircuit Technologies vs

Reimagining the Treatment of Pelvic Health Disorders

Series A
12 employees
Health Care, Medical Devices
BioCircuit Technologies vs
KLISBio
KLISBio Italy

Silk innovation for life sciences

Grant
15 employees
Biotechnology, Health Care

FAQ About BioCircuit Technologies

Precision made simple
BioCircuit Technologies was founded in 2016.
BioCircuit Technologies is headquartered in Atlanta, United States.
BioCircuit Technologies operates in Biotechnology, Health Care, Manufacturing and Medical Devices. Its work centres on electrophysiology, nerve repair, tissue repair and noninvasive.
BioCircuit Technologies has approximately 30 employees.
BioCircuit Technologies has completed 5 funding rounds, raising a total of $14.60M. The latest funding stage is Grant.
Top alternatives and competitors to BioCircuit Technologies include bioAffinity Technologies, EBT Medical, Inc., KLISBio, CoNextions Medical, Serica. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioCircuit Technologies and bioAffinity Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioCircuit Technologies, https://bouncewatch.com/company/biocircuit-technologies, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes